<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02302027</url>
  </required_header>
  <id_info>
    <org_study_id>ARCUC</org_study_id>
    <nct_id>NCT02302027</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache</brief_title>
  <acronym>O214</acronym>
  <official_title>Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache With or Without Abuse of Painkillers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association pour la Recherche au Centre d'Urgence des Céphalées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association pour la Recherche au Centre d'Urgence des Céphalées</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic headache is most often associated with drug abuse and medication overuse headache
      (MOH) is the main complication of migraine disease results in chronic daily headache. The
      first phase of treatment consists of drug withdrawal .

      The second phase of treatment (called consolidation) is to maintain the balance: treating
      headaches and reducing / stopping the drug use.

      The aim of this study is

        1. verify the feasibility of a home withdrawal treatment with normobaric oxygen therapy
           (NOT) delivery by high flow concentrator

        2. use normobaric oxygen therapy (NOT) as a therapeutic measure to treat headache through
           withdrawal period.

      It is a feasibility pilot study in chronic headache with or without medication-overuse. All
      patients receive a care for outpatient withdrawal that involves sudden stop drug abuse and
      used to be called &quot;traditional management&quot;. The subsequent attacks will be treated with NOT
      from a high-flow concentrator

      Primary endpoint. Feasibility study of treatment with NOT evaluated by the percentage of
      patients who accepted NOT during the withdrawal phase then to treat attacks.

      Secondary endpoints. Efficacy will be assessed by the percentage of patients having no
      chronic headaches two months after the start of withdrawal (less than 15 days of headache per
      month) and no longer in drug abuse (less than 10 days per month with drug intake).

      Visits V1 (first visit) Inclusion V2 at one month V3 at 3 months V4 (last vist) at 6 months

      Effective : 30 patients
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients accepted the normobaric oxygen treatment during withdrawal and consolidation phases</measure>
    <time_frame>6th month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of headache days per month</measure>
    <time_frame>6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of session of oxygen during the 6 months</measure>
    <time_frame>6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of rescue medication taking on the 6 months</measure>
    <time_frame>6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>1st month, 2d month and 3rd month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache Impact Test- 6</measure>
    <time_frame>1st, 2d and 3rd month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impressions of Change Scale</measure>
    <time_frame>1st, 2d, 3rd, 4th, 5th and 6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migraine Disability Assessment Questionnaire Scale</measure>
    <time_frame>3rd and 6th month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Headache</condition>
  <arm_group>
    <arm_group_label>platinium IRC9LXO2AWQ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normobaric oxygen therapy with high flow concentrator to treat headaches attacks, 30 minutes of oxygene inhalation with mask, 9l/minute, no frequency limitation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>platinium IRC9LXO2AWQ</intervention_name>
    <description>high flow concentrator delivering normobaric oxygen after extraction, 9 liter per minute dimensions: 46 * 67 * 36 cm</description>
    <arm_group_label>platinium IRC9LXO2AWQ</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Migrainous according to the criteria of the International Headache Society

          -  Medication-overuse headaches according of the International Headache Society

          -  No prophylaxis treatment or same prophylaxis treatment from more than one month

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  One or more failed withdrawal treatment

          -  analgesic treatment for another reason than headache

          -  Contraindication of normobaric oxygen therapy

          -  Contraindication of ketoprofen (rescue therapy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caroline Roos, MD</last_name>
    <phone>00 33 1 49 95 89 53</phone>
    <email>caroline.roos@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre d'Urgence des Céphalées, hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Roos, MD</last_name>
      <phone>00 33 1 49 95 89 53</phone>
      <email>caroline.roos@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique Valade, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline Roos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cecilia Burcin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jérôme Mawet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Kavuk I, Katsarava Z, Selekler M, Sayar K, Agelink MW, Limmroth V, Diener HC. Clinical features and therapy of medication overuse headache. Eur J Med Res. 2004 Dec 22;9(12):565-9. Review.</citation>
    <PMID>15689304</PMID>
  </results_reference>
  <results_reference>
    <citation>Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C. Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia. 2005 Dec;25(12):1146-58.</citation>
    <PMID>16305603</PMID>
  </results_reference>
  <results_reference>
    <citation>Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 Apr;9(4):391-401. doi: 10.1016/S1474-4422(10)70008-9. Review.</citation>
    <PMID>20298963</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2014</study_first_submitted>
  <study_first_submitted_qc>November 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2014</study_first_posted>
  <last_update_submitted>January 6, 2016</last_update_submitted>
  <last_update_submitted_qc>January 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association pour la Recherche au Centre d'Urgence des Céphalées</investigator_affiliation>
    <investigator_full_name>Caroline ROOS</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>withdrawal therapy</keyword>
  <keyword>oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Headache Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

